CME Topic

Bronchus-Associated Lymphoid Tissue Lymphomas

Authors: Konstantinos Arnaoutakis MD, Thein H. Oo MD

Abstract

Background:Bronchus-associated Lymphoid Tissue (BALT) lymphomas are a rare type of extranodal marginal zone lymphomas. They comprise 1% of lymphomas and more than two-thirds of all primary non-Hodgkin lymphoma (NHL) of the lung. BALT lymphomas arise from the bronchus-associated lymphoid tissue.Methods:This report describes five cases of BALT lymphoma and discusses the pathogenesis, diagnosis, prognosis and treatment of BALT lymphomas.Results:In our cohort of patients, patients were managed with surgery, watchful waiting, chemotherapy, immunotherapy, and chemoimmunotherapy. The outcomes are excellent and projected 5-year survival is 100%.Discussion:BALT lymphomas are associated with chronic inflammation, and they are often asymptomatic. They have an indolent course and the survival outcome is excellent with different treatment modalities such as surgery, watchful waiting, radiotherapy, chemotherapy, immunotherapy or chemoimmunotherapy.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Kocks JR, Davalos-Misslitz AC, Hintzen G, et al. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med 2007;204:723–734.KocksJR]]Davalos-MisslitzAC]]HintzenG&etal;Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue.J Exp Med2007204723-7342. Escolar Castellón JD, Escolar Castellón A, Roche Roche PA, et al. Bronchial-associated lymphoid tissue (BALT) response to airway challenge with cigarette smoke, bovine antigen and anti-pulmonary serum. Histol Histopathol 1992;7:321–328.Escolar CastellónJD]]Escolar CastellónA]]Roche RochePA&etal;Bronchial-associated lymphoid tissue (BALT) response to airway challenge with cigarette smoke, bovine antigen and anti-pulmonary serum.Histol Histopathol19927321-3283. Rangel-Moreno J, Hartson L, Navarro C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183–3194.Rangel-MorenoJ]]HartsonL]]NavarroC&etal;Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.J Clin Invest20061163183-31944. Zucca E, Bertoni F, Stathis A, et al. Marginal zone lymphomas. Hematol Oncol Clin North Am 2008;22:883–901, viii.ZuccaE]]BertoniF]]StathisA&etal;Marginal zone lymphomas.Hematol Oncol Clin North Am200822883-901, viii5. Inadome Y, Ikezawa T, Oyasu R, et al. Malignant lymphoma of bronchus-associated lymphoid tissue coexistent with pulmonary tuberculosis. Pathol Int 2001;51:807–811.InadomeY]]IkezawaT]]OyasuR&etal;Malignant lymphoma of bronchus-associated lymphoid tissue coexistent with pulmonary tuberculosis.Pathol Int200151807-8116. Richmond I, Pritchard GE, Ashcroft T, et al. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 1993;48:1130–1134.RichmondI]]PritchardGE]]AshcroftT&etal;Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers.Thorax1993481130-11347. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007;28:369–378.LeslieKO]]TrahanS]]GrudenJPulmonary pathology of the rheumatic diseases.Semin Respir Crit Care Med200728369-3788. Zinzani PL, Poletti V, Zompatori M, et al. Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma. Clin Lymphoma Myeloma 2007;7:566–572.ZinzaniPL]]PolettiV]]ZompatoriM&etal;Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma.Clin Lymphoma Myeloma20077566-5729. Takino H, Okabe M, Li C, et al. p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis. Mod Pathol 2005;18:1187–1192.TakinoH]]OkabeM]]LiC&etal;p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis.Mod Pathol2005181187-119210. Remstein ED, Kurtin PJ, Einerson RR, et al. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 2004;18:156–160.RemsteinED]]KurtinPJ]]EinersonRR&etal;Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1.Leukemia200418156-16011. Chng WJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood 2009;113:635–645.ChngWJ]]RemsteinED]]FonsecaR&etal;Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications.Blood2009113635-64512. Ahmed S, Kussick SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004;40:1320–1326.AhmedS]]KussickSJ]]SiddiquiAK&etal;Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.Eur J Cancer2004401320-132613. Isaacson PG, Muller-Hermelink, Piris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma, in Jaffe ES, Harris NL, Stein H, Vardiman JW, (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp 157–160.IsaacsonPG]]Muller-Hermelink]]PirisMA&etal;Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma,Jaffe ES, Harris NL, Stein H, Vardiman JWWorld Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues.LyonIARC Press2001157-16014. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999;14:423–429.WislezM]]CadranelJ]]AntoineM&etal;Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations.Eur Respir J199914423-42915. Takamori M, Noma S, Kobashi Y, et al. CT findings of BALTOMA. Radiat Med 1999;17:349–354.TakamoriM]]NomaS]]KobashiY&etal;CT findings of BALTOMA.Radiat Med199917349-35416. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J 2002;20:750–762.CadranelJ]]WislezM]]AntoineMPrimary pulmonary lymphoma.Eur Respir J200220750-76217. Arkenau HT, Gordon C, Cunningham D, et al. Mucosa associated lymphoid tissue of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma 2007;48:547–550.ArkenauHT]]GordonC]]CunninghamD&etal;Mucosa associated lymphoid tissue of the lung: the Royal Marsden Hospital experience.Leuk Lymphoma200748547-55018. Perceau G, Diris N, Estines O, et al. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006;155:1053–1056.PerceauG]]DirisN]]EstinesO&etal;Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.Br J Dermatol20061551053-105619. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001;345:1000.SuzanF]]AmmorM]]RibragVFatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.N Engl J Med2001345100020. Teichmann LL, Woenckhaus M, Vogel C, et al. Fatal pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1256–1257.TeichmannLL]]WoenckhausM]]VogelC&etal;Fatal pneumocystis pneumonia following rituximab administration for rheumatoid arthritis.Rheumatology (Oxford)2008471256-125721. Kim JH, Lee SH, Park J. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol 2004;34:510–514.KimJH]]LeeSH]]ParkJPrimary pulmonary non-Hodgkin’s lymphoma.Jpn J Clin Oncol200434510-514